Expanded HIV Testing in the Emergency Department CME

Author Information and Disclosures

Release Date: March 31, 2008Valid for credit through March 31, 2009

Credits Available
Physicians - maximum of 2.0 AMA PRA Category 1 Credit(s) for physicians

To participate in this internet activity: (1) review the target audience, learning objectives, and author disclosures; (2) study the education content; (3) take the post-test and/or complete the evaluation; (4) view/print certificate View details.

Contents of This CME Activity

  1. Expanded HIV Testing in the Emergency Department: Implementing the CDC RecommendationsDr. Bernard M. Branson discusses the rationale for the CDC guidelines for expanded HIV testing in the emergency department and outlines strategies for their implementation.
  2. HIV Testing in the Emergency Department: An Expert Interview With Richard E. Rothman, MD, PhD, FACEPRichard E. Rothman, MD, discusses the implementation of the CDC guidelines for HIV testing in the emergency department.
  3. HIV Testing in the Emergency DepartmentDr. Jason S. Haukoos presents the case of a 32-year-old man seen in the ED with dyspnea on exertion, low-grade fever, and mild chills. Should he be tested for HIV?

Legal Disclaimer

The material presented here does not necessarily reflect the views of Medscape or companies that support educational programming on www.medscape.com. These materials may discuss therapeutic products that have not been approved by the US Food and Drug Administration and off-label uses of approved products. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or employing any therapies described in this educational activity.

Copyright © 2008 Medscape.


Gilead

Learning Objectives

Upon completion of this activity, participants will be able to:

  1. Discuss issues specific to the implementation of opt-out HIV testing in the emergency department (ED)
  2. Discuss options for implementing HIV testing in the ED
  3. Describe the CDC's new recommendations for HIV screening and the rationale for this change
Authors and Disclosures

Bernard M. Branson, MD
Disclosure: Bernard M. Branson, MD, has disclosed no relevant financial relationships.


Richard E. Rothman, MD, PhD, FACEP
Disclosure: Richard E. Rothman, MD, PhD, FACEP, has disclosed that he has received grants for clinical research from Gilead and OraSure Technologies, and has received grants for educational activities from Gilead. Dr. Rothman has also disclosed that he has served as an advisor or consultant to OraSure Technologies.


Jason S. Haukoos, MD, MSc
Disclosure: Jason S. Haukoos, MD, MSc, has disclosed that he has received grants for clinical research from Abbott and Centers for Disease Control and Prevention and has served as an advisor or consultant to OraSure Technologies.


Margaret A. Clark, RN, RRT-NPS
Disclosure: Margaret A. Clark, RN, RRT-NPS, has disclosed no relevant financial relationships.


Thomas Maxwell Mundy, MD
Disclosure: Thomas Maxwell Mundy, MD, has disclosed no relevant financial relationships.


Sussan K. Sutphen, MD, MEd
Disclosure: Sussan K. Sutphen, MD, MEd, has disclosed no relevant financial relationships.


 
Medscape
Medscape, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Medscape, LLC designates this educational activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

Contact This Provider

All material on this website is protected by copyright, Copyright © 1994-2008 by Medscape. This website also contains material copyrighted by 3rd parties.